Steady state (no accumulation) [Regulatives / Guidelines]

posted by Ohlbe – France, 2011-06-06 15:54 (5081 d 03:34 ago) – Posting: # 7075
Views: 10,068

Dear Helmut,

❝ Agree with the former, but not the latter. From my little story: CVs for AUCt ≈7 %, Cmax ≈15 %, Cmin1 ≈75 %. According to the current NfG Cmin is required – no scaling (EMA is considering scaling for HVDs/HVDPs if accumulation occurs as an alternative to multiple dose studies). For the usual stuff (AR 80–125%, α≤0.05, power 80%, PE 0.95) that would require increasing the sample size from 12 to 194 (!) in a 2×2 cross-over.


True, I forgot this part of the problem :-(

Regards
Ohlbe

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,666 registered users;
61 visitors (0 registered, 61 guests [including 8 identified bots]).
Forum time: 19:28 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5